Relationship between an effective dose of imatinib, body surface area, and trough drug levels in patients with chronic myeloid leukemia (2009)
川口, 辰哉,
濱田, 哲暢,
南部, 健,
山川, 裕司,
渡邊, 博志,
堀川, 健太郎,
...
The standard dose of imatinib for the treatment of chronic-phase chronic myeloid leukemia (CML) is 400 mg/day. Some patients receive reduced doses of imatinib because of serious adverse effects....